AAQ1 — Aap Implantate AG Income Statement
0.000.00%
Last trade - 00:00
- €13.91m
- €14.87m
- €11.52m
- 26
- 44
- 72
- 42
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 10.8 | 11.7 | 9.33 | 12.2 | 11.5 |
Cost of Revenue | |||||
Gross Profit | 10.3 | 10.6 | 7.96 | 10.9 | 10.6 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 18.9 | 31.5 | 17.2 | 14.8 | 14.9 |
Operating Profit | -8.13 | -19.8 | -7.89 | -2.61 | -3.39 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -7.65 | -20 | -8.82 | -2.86 | -3.61 |
Provision for Income Taxes | |||||
Net Income After Taxes | -7.67 | -19.4 | -8.94 | -2.52 | -2.56 |
Net Income Before Extraordinary Items | |||||
Net Income | -7.67 | -19.4 | -8.94 | -2.52 | -2.56 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -7.67 | -19.4 | -8.94 | -2.52 | -2.56 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.1 | -4.63 | -1.67 | -0.417 | -0.43 |
Dividends per Share |